Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure

Summary

In this study, TRV120027 (or a placebo) intravenous infusion will be given to people with heart failure to learn about the effects of TRV120027. The results of this study will help choose the proper range of TRV120027 doses to use in future research studies involving patients with acute decompensated heart failure.

Timeline

Start

2010-12

Primary completion

2012-03

Completion

2012-03

Drugs

Indications